Pharmaceutical Companies Might Like Type 1 Diabetes
In 1990 a scientist working at Stanford University was able to completely cure type 1 Diabetes in mice using stem cells. Not using the controversial embryo stem cell research but using adult stem cells, but no one would pick it up for clinical trials. There are many of us who believe that the big pharmaceutical companies would rather you purchase insulin a couple of times of day, than be cured once. It just makes good business sense. A legal junkie who will return for a fix day after day for his “stuff”, and in the case of a diabetic it is for a lifetime.
Irving Weissman is that scientist and he is still a professor of pathology and developmental biology today at Stanford University. He has been right before. For instance 12 years ago he discovered a treatment for women with late stage breast cancer and it was ignored. He agrees that pharmaceutical companies would rather do good business than good health; and has spoken out against just those businesses.
Weissman was a guest speaker at Columbia University in a lecture series that is held specifically for religions about science. It is important to understand how stem cell research does not have to go against individuals moral beliefs. Perhaps with some renewed press Weissman can bring his cure for type 1 diabetes into reality. I know plenty of people, their families and perhaps even their insurance companies that would be glad to see science abolish another disease.
